131 results
Page 2 of 7
425
u39h 0c2b8r1
4 Oct 23
Business combination disclosure
4:33pm
425
uw5b924z8fxw14uhfhcd
2 Oct 23
Business combination disclosure
5:31pm
8-K
89t6nuf0c1xjnrv suw
2 Oct 23
Other Events
5:30pm
425
a1n345 2beedx
18 Sep 23
Business combination disclosure
5:27pm
8-K
tfhmyuv wf
18 Sep 23
Other Events
5:27pm
425
EX-99.1
js2eenf jg
6 Sep 23
Business combination disclosure
8:17am
8-K
EX-99.1
7yurm9qd2ry
6 Sep 23
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
8:13am
424B3
aa0 w2sa2
5 Sep 23
Prospectus supplement
6:02pm
425
EX-99.1
3aqs9jybyyn0
14 Aug 23
Business combination disclosure
8:06am
8-K
EX-99.1
z6djgket4gbwtc
14 Aug 23
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
8:05am
S-4/A
p9oho8utc1zk9
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
hkbnw84ay3wx4h0 ij
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
425
mur1u9acuv6j1xj
9 Jun 23
Business combination disclosure
4:31pm
425
1bm sbn4ncbxm1bl3s
17 May 23
Business combination disclosure
4:54pm
10-Q
txpfwc2e k6g0egzp
15 May 23
Quarterly report
4:30pm
425
EX-99.1
5oh9ef2ls
15 May 23
Business combination disclosure
4:06pm